Akari Therapeutics PLC-ADRAKTX
13F holders, Q2 2026 (June 30)9holders +3
5new positions
2sold out
$10.24avg. 13F price*
At the end of Q2 2026, 9 institutions reported holding Akari Therapeutics PLC-ADR (AKTX) in their 13F filings, up 3 from Q1 2026. 5 opened new positions and 2 sold out. The largest holders were MMCAP International Inc. SPC ($1.0M), Cresset Asset Management, LLC ($211K) and Jane Street Group, LLC ($158K).
- Company
- Akari Therapeutics PLC-ADR
- CUSIP
- 00972G405
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $1.3M |
| Exits | 2 | $200K |
All 13F filers, Q1 2026 → Q2 2026: 129,232 shares bought and 38,923 shares sold, net +90,309 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| MMCAP International Inc. SPC | 0.09% | New | 100,000 | $1.0M |
| Cresset Asset Management, LLC | 0.00% | No change | 20,561 | $211K |
| Jane Street Group, LLC | 0.00% | New | 15,463 | $158K |
| HRT Financial LP | 0.00% | New | 13,745 | $140K |
| IFP Advisors, Inc | 0.00% | No change | 181 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +180.0% | 14 | $143 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 8 | $82 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 7 | $72 |
| Truvestments Capital LLC | 0.00% | No change | 1 | $10 |
"% of holder's portfolio" is AKTX's weight in each manager's 13F, not the share of Akari Therapeutics PLC-ADR the manager owns.